Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab vs Tacrolimus in EDC Kidney Transplant
NCT00302497Phase 3Unknown
- Sponsor
- McGill University Health Centre
- Start
- Apr 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of basiliximab in kidney transplantation, sponsored by McGill University Health Centre. Primary endpoint: Annualised change in GFR at 12 months. Status: unknown.
02
Drugs
basiliximab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00302497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302497.